跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38,314 条关于
“Livzon Pharmaceutical Group”
全部
38,314
临床试验
18,525
药物
2,121
机构
2,572
资讯
15,096
4个月前
Livzon Pharmaceutical Receives Regulatory Approval for Brexpiprazole Microsphere Clinical Trial in Adult Schizophrenia
3个月前
Livzon's IL-17 Inhibitor Lecankitug Nears Second Indication as NMPA Accepts Ankylosing Spondylitis Application
去年
Livzon's Dual-Target IL-17A/F Antibody LZM012 Outperforms Secukinumab in Phase III Psoriasis Trial
去年
Onconic's Jaqbo Shows 100% Efficacy in Phase 3 Gastric Ulcer Trial, Seeks Indication Expansion
去年
Jeil Pharm Launches Jaqbo, a Novel P-CAB for Peptic Ulcer Treatment in Korea
去年
Grand Pharmaceutical's ITM-11 Phase III Trial Accepted for GEP-NETs in China
去年
Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer
6个月前
EVE Health Group Secures $904,000 to Advance Reformulated Pharmaceutical Pipeline
去年
Hansoh Pharma's Aumolertinib Plus Chemotherapy Shows Positive Phase III Results in EGFR-Mutated NSCLC
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for ES-SCLC
第 1 页，共 1510 页
上一页
下一页
